Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: EC:3.4.25.1 (
proteasome
)
28,817
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
The chaperone-related p97 protein plays a central role in various cellular processes involving the ubiquitin-
proteasome
system. The diverse functions of p97 are controlled by a large number of cofactors that recruit specific substrates or influence their ubiquitylation state. Many cofactors bind through a UBX or PUB domain, two major p97 binding modules. However, the recently identified
UBXD1
cofactor possesses both domains. To elucidate the molecular basis underlying the interaction between
UBXD1
and p97, we analyzed the contribution of both domains to p97 binding biochemically and in living cells. The PUB domain mediated robust binding to the carboxy-terminus of p97, while the UBX domain did not contribute to p97 binding. Importantly, we identified an additional p97 binding site in
UBXD1
that competed with the p47 cofactor for binding to the N domain of p97. This novel, bipartite binding mode suggests that
UBXD1
could be an efficient regulator of p97 cofactor interactions.
...
PMID:UBXD1 binds p97 through two independent binding sites. 1917 49
UBXD1
is a recently identified adaptor for p97, a highly abundant and conserved member of the AAA family of ATPase that plays pivotal roles in a multitude of cellular processes involving the ubiquitin-
proteasome
pathway. Very little is known about the biochemical, cellular, and molecular functions of
UBXD1
. Here we report the generation of two mouse monoclonal antibodies, 5C3-1 and 2F8-24, that recognize
UBXD1
using Western blotting, immunoprecipitation, and immunofluorescence.
...
PMID:Generation and characterization of novel monoclonal antibodies recognizing UBXD1. 2002 8
The AAA-ATPase p97 (also called VCP for Valosin-containing protein) is essential for a number of cellular processes as diverse as ER-associated degradation, DNA damage response, and cell cycle control. Mechanistically, p97 cooperates with its cofactor Ufd1-Npl4 in these processes to segregate polyubiquitinated misfolded or regulatory client proteins from intracellular structures for subsequent degradation by the
proteasome
. Recent work now connects p97, independently of Ufd1-Npl4, to endosomal trafficking and autophagy. Interestingly, these pathways also deliver proteins for degradation, albeit by the lysosome. While monoubiquitination and alternative p97-cofactors, including
UBXD1
, have been associated with these activities, the underlying molecular mechanism(s) are still unclear or controversial. In this review, we aim to summarize the available data and discuss mechanistic models.
...
PMID:Expanding into new markets--VCP/p97 in endocytosis and autophagy. 2245 Feb 27